Fig. 4From: MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt/β-cadherin pathwayHOXA9 was upregulated in breast cancer tissues. (A, B) The protein expression of HOXA9 in breast cancer tissues detected by immunohistochemistry. (C) High HOXA9 expression was related to shorter overall survival of breast cancer patients. *P < 0.05Back to article page